Reuters logo
BRIEF-Meridian Bioscience comments on FDA statement concerning inspection of Magellan diagnostics
2017年7月13日 / 下午5点55分 / 4 个月前

BRIEF-Meridian Bioscience comments on FDA statement concerning inspection of Magellan diagnostics

July 13 (Reuters) - Meridian Bioscience Inc :

* Meridian Bioscience comments on recent FDA press statement

* Meridian Bioscience Inc- ‍Consistent with FDA policy, Magellan will promptly submit responses to form FDA-483 for agency’s consideration​

* Meridian Bioscience - Providing comments regarding FDA statement concerning posting of form FDA-483 issued following inspection of Magellan diagnostics Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below